References
- Bottomley A. The cancer patient and quality of life. Oncologist. 2002;7:120–125.
- Yang D, Hendifar A, Lenz C, et al. Survival of metastatic gastric cancer: significance of age, sex and race/ethnicity. J Gastrointest Oncol. 2011;2:77–84.
- Montazeri A. Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes. 2009;7:102.
- Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res. 2008;27:32.
- Project data sphere. [cited 2017 Jul 10]. Available from: https://www.projectdatasphere.org/projectdatasphere/html/home
- Van Cutsem E, Moiseyenko VM, Tjulandin S, et al. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 study group. J Clin Oncol. 2006;24:4991–4997.
- Lordick F, Kang YK, Chung HC, et al. Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial. Lancet Oncol. 2013;14:490–499.
- Oppe M, Devlin NJ, Szende A. EQ-5D value sets: inventory, comparative review and user guide. Springer; 2007. https://www.springer.com/gp/book/9781402055102.
- EQ-5D index calculator. [cited 2018 Sep 14]. Available from: https://www.economicsnetwork.ac.uk/health/EQ_5D_index_calculator.xls
- Ediebah DE, Quinten C, Coens C, et al. Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials. Cancer. 2018;124:3409–3416.
- Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non–small-cell lung cancer. N Engl J Med. 2010;363:733–742.
- Abdel-Rahman O. Impact of diabetes comorbidity on the efficacy and safety of FOLFOX first-line chemotherapy among patients with metastatic colorectal cancer: a pooled analysis of two phase-III studies. Clin Transl Oncol. 2018.
- Lee JH, Park B, Joo J, et al. Body mass index and mortality in patients with gastric cancer: a large cohort study. 2018 Nov;21(6):913-924.
- Greenleaf EK, Kulaylat AN, Hollenbeak CS, et al. Timing of adjuvant chemotherapy and impact on survival for resected gastric cancer. Ann Surg Oncol. 2016;23:4203–4213.
- Oweira H, Giryes A, Mannhart M, et al. Impact of time to start systemic therapy on the outcomes of patients with metastatic colorectal cancer treated with first-line FOLFOX chemotherapy; a patient-level pooled analysis of two clinical trials. Expert Rev Gastroenterol Hepatol. 2018 Oct;12(10):1069-1074.
- Bujanda L, Rodríguez-González A, Sarasqueta C, et al. Effect of pravastatin on the survival of patients with advanced gastric cancer. Oncotarget. 2016;7:4379–4384.